P/E at 60.15 vs Industry's 56.45: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium Above Industry Average

The current P/E of Apollo Hospitals Enterprise Ltd. stands at 60.15, exceeding the hospital industry’s average P/E of 56.45 by approximately 6.5%. This premium suggests that investors are willing to pay more for each rupee of earnings relative to peers, reflecting expectations of superior earnings growth or a perception of higher quality. However, such a valuation also implies heightened sensitivity to earnings disappointments or sector headwinds. The premium is not excessive but does warrant scrutiny, especially given the recent reassessment from a previous Buy rating — what is the current rating?

Performance Across Timeframes: Divergent Momentum

Examining returns over various periods reveals a complex performance profile. Over the past year, Apollo Hospitals Enterprise Ltd. has delivered a robust 16.79% gain, significantly outperforming the Sensex’s decline of 4.14%. This outperformance extends over longer horizons as well, with three-year returns at 74.50% versus the Sensex’s 29.03%, and an impressive ten-year return of 442.97% compared to 193.61% for the benchmark.

Yet, the short-term picture is less favourable. The stock has declined 3.60% over the past month, though this still outperforms the Sensex’s 8.48% fall. More intriguingly, the three-month return is a positive 5.37%, contrasting with the Sensex’s 12.52% drop. This suggests that while the stock has shown resilience relative to the broader market, recent volatility has tempered gains. The 1-week return of 2.38% also outpaces the Sensex’s slight decline of 0.19%, but the one-day performance shows a 0.57% drop, underperforming the Sensex’s 1.17% fall. This mixed momentum profile raises the question — is this a recovery or a dead-cat bounce? — the moving average configuration provides the clearest answer.

Moving Average Configuration: Mixed Technical Signals

The technical setup for Apollo Hospitals Enterprise Ltd. reveals a nuanced trend. The stock price currently trades above its 5-day, 50-day, 100-day, and 200-day moving averages, signalling underlying strength and a recovery from recent lows. However, it remains below the 20-day moving average, indicating some short-term resistance and potential consolidation. This configuration often points to a stock in a recovery phase within a broader trend, where short-term momentum is still catching up to longer-term gains. The recent two-day consecutive gain was followed by a decline, reflecting this tussle between buyers and sellers. The 20-day moving average acts as a critical hurdle — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Sector Context: Hospital Industry Performance

The hospital sector has experienced mixed results recently, with a combination of positive, flat, and negative performances across constituent stocks. Apollo Hospitals Enterprise Ltd. stands out as one of the better performers over the medium and long term, consistently outperforming the sector average. The sector’s average P/E of 56.45 reflects moderate valuation levels, with Apollo Hospitals trading at a premium that suggests investor confidence in its market position and earnings quality. However, the sector’s recent volatility and mixed results highlight the importance of monitoring short-term developments closely.

Rating Context: Previously Rated Buy, Now Reassessed

MarketsMOJO had previously assigned a Buy rating to Apollo Hospitals Enterprise Ltd. The Mojo Score currently stands at 52.0, with the latest rating update occurring on 09 Jan 2026. This reassessment reflects the evolving valuation and performance dynamics, particularly the premium valuation and the mixed short-term momentum. The rating update invites investors to reconsider the stock’s position within their portfolios — should investors in Apollo Hospitals hold, buy more, or reconsider?

Conclusion: A Complex Picture Emerging from the Data

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap stock trading at a modest premium to its sector, with strong long-term returns but mixed short-term momentum. The moving average configuration suggests a recovery phase, yet the stock faces resistance at the 20-day moving average. The reassessment from a previous Buy rating reflects these complexities, urging a closer look at valuation and technical signals. The hospital sector’s mixed performance further underscores the need for careful analysis before making portfolio decisions — what is the current rating?

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →